ID   PTPRF_HUMAN             Reviewed;        1907 AA.
AC   P10586; D3DPX6; D3DPX7; Q5T021; Q5T022; Q5W9G2; Q86WS0;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   24-MAR-2009, sequence version 2.
DT   28-JUN-2023, entry version 246.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase F;
DE            EC=3.1.3.48;
DE   AltName: Full=Leukocyte common antigen related;
DE            Short=LAR;
DE   Flags: Precursor;
GN   Name=PTPRF; Synonyms=LAR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Tonsil;
RX   PubMed=2972792; DOI=10.1084/jem.168.5.1523;
RA   Streuli M., Krueger N.X., Hall L.R., Schlossman S.F., Saito H.;
RT   "A new member of the immunoglobulin superfamily that has a cytoplasmic
RT   region homologous to the leukocyte common antigen.";
RL   J. Exp. Med. 168:1523-1530(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15491607; DOI=10.1016/j.jmb.2004.09.028;
RA   Homma K., Kikuno R.F., Nagase T., Ohara O., Nishikawa K.;
RT   "Alternative splice variants encoding unstable protein domains exist in the
RT   human brain.";
RL   J. Mol. Biol. 343:1207-1220(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Retinoblastoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   MUTAGENESIS.
RX   PubMed=2554325; DOI=10.1073/pnas.86.22.8698;
RA   Streuli M., Krueger N.X., Tsai A.Y.M., Saito H.;
RT   "A family of receptor-linked protein tyrosine phosphatases in humans and
RT   Drosophila.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8698-8702(1989).
RN   [7]
RP   MUTAGENESIS.
RX   PubMed=1695146; DOI=10.1002/j.1460-2075.1990.tb07415.x;
RA   Streuli M., Krueger N.X., Thai T., Tang M., Saito H.;
RT   "Distinct functional roles of the two intracellular phosphatase like
RT   domains of the receptor-linked protein tyrosine phosphatases LCA and LAR.";
RL   EMBO J. 9:2399-2407(1990).
RN   [8]
RP   INTERACTION WITH INSR.
RX   PubMed=8995282; DOI=10.1074/jbc.272.11.7519;
RA   Ahmad F., Goldstein B.J.;
RT   "Functional association between the insulin receptor and the transmembrane
RT   protein-tyrosine phosphatase LAR in intact cells.";
RL   J. Biol. Chem. 272:448-457(1997).
RN   [9]
RP   INTERACTION WITH PPFIA1; PPFIA2 AND PPFIA3.
RX   PubMed=9624153; DOI=10.1074/jbc.273.25.15611;
RA   Serra-Pages C., Medley Q.G., Tang M., Hart A., Streuli M.;
RT   "Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-
RT   interacting proteins.";
RL   J. Biol. Chem. 273:15611-15620(1998).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-966.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-966.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   FUNCTION IN EPHA2 DEPHOSPHORYLATION.
RX   PubMed=23358419; DOI=10.1128/mcb.01708-12;
RA   Lee H., Bennett A.M.;
RT   "Receptor protein tyrosine phosphatase-receptor tyrosine kinase substrate
RT   screen identifies EphA2 as a target for LAR in cell migration.";
RL   Mol. Cell. Biol. 33:1430-1441(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1305, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1334-1897, FUNCTION, AND
RP   MUTAGENESIS OF CYS-1548.
RX   PubMed=10338209; DOI=10.1016/s0092-8674(00)80755-2;
RA   Nam H.J., Poy F., Krueger N.X., Saito H., Frederick C.A.;
RT   "Crystal structure of the tandem phosphatase domains of RPTP LAR.";
RL   Cell 97:449-457(1999).
RN   [16]
RP   STRUCTURE BY NMR OF 319-415 AND 596-1010.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structures of FN3 domains of human receptor-type tyrosine-protein
RT   phosphatase F.";
RL   Submitted (AUG-2007) to the PDB data bank.
RN   [17]
RP   INVOLVEMENT IN BNAH2.
RX   PubMed=24781087; DOI=10.1007/s00439-014-1445-1;
RA   Borck G., de Vries L., Wu H.J., Smirin-Yosef P., Nurnberg G., Lagovsky I.,
RA   Ishida L.H., Thierry P., Wieczorek D., Nurnberg P., Foley J., Kubisch C.,
RA   Basel-Vanagaite L.;
RT   "Homozygous truncating PTPRF mutation causes athelia.";
RL   Hum. Genet. 133:1041-1047(2014).
CC   -!- FUNCTION: Possible cell adhesion receptor. It possesses an intrinsic
CC       protein tyrosine phosphatase activity (PTPase) and dephosphorylates
CC       EPHA2 regulating its activity.
CC   -!- FUNCTION: The first PTPase domain has enzymatic activity, while the
CC       second one seems to affect the substrate specificity of the first one.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- SUBUNIT: Interacts with GRIP1 (By similarity). Interacts with PPFIA1,
CC       PPFIA2 and PPFIA3. Interacts with INSR. {ECO:0000250,
CC       ECO:0000269|PubMed:8995282, ECO:0000269|PubMed:9624153}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P10586-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P10586-2; Sequence=VSP_036617;
CC   -!- DISEASE: Aplasia or hypoplasia of the breasts and/or nipples 2 (BNAH2)
CC       [MIM:616001]: A group of congenital deformities encompassing total
CC       absence of breasts and nipple (amastia), absence of the nipple
CC       (athelia), and absence of the mammary gland (amazia).
CC       {ECO:0000269|PubMed:24781087}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 2A subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD66835.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA68754.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00815; CAA68754.1; ALT_INIT; mRNA.
DR   EMBL; AB177857; BAD66835.1; ALT_INIT; mRNA.
DR   EMBL; AC092815; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL583862; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07086.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07087.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07088.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07089.1; -; Genomic_DNA.
DR   EMBL; BC048768; AAH48768.1; -; mRNA.
DR   CCDS; CCDS489.2; -. [P10586-1]
DR   CCDS; CCDS490.2; -. [P10586-2]
DR   PIR; S03841; TDHULK.
DR   RefSeq; NP_002831.2; NM_002840.4. [P10586-1]
DR   RefSeq; NP_569707.2; NM_130440.3. [P10586-2]
DR   PDB; 1LAR; X-ray; 2.00 A; A/B=1333-1907.
DR   PDB; 2DJU; NMR; -; A=319-411.
DR   PDB; 2DN7; NMR; -; A=821-914.
DR   PDB; 2EDX; NMR; -; A=596-716.
DR   PDB; 2EDY; NMR; -; A=915-1010.
DR   PDB; 2YD5; X-ray; 2.20 A; A=29-231.
DR   PDB; 2YD8; X-ray; 2.05 A; A=29-231.
DR   PDB; 4N5U; X-ray; 1.46 A; A=601-705.
DR   PDB; 6KR4; X-ray; 2.85 A; A/B/C/D=1332-1907.
DR   PDB; 6TPT; X-ray; 3.20 A; A=512-706.
DR   PDB; 6TPU; X-ray; 1.55 A; A/B=513-706.
DR   PDB; 6TPV; X-ray; 1.80 A; A/B=319-512.
DR   PDB; 6TPW; X-ray; 2.90 A; A=319-706.
DR   PDBsum; 1LAR; -.
DR   PDBsum; 2DJU; -.
DR   PDBsum; 2DN7; -.
DR   PDBsum; 2EDX; -.
DR   PDBsum; 2EDY; -.
DR   PDBsum; 2YD5; -.
DR   PDBsum; 2YD8; -.
DR   PDBsum; 4N5U; -.
DR   PDBsum; 6KR4; -.
DR   PDBsum; 6TPT; -.
DR   PDBsum; 6TPU; -.
DR   PDBsum; 6TPV; -.
DR   PDBsum; 6TPW; -.
DR   AlphaFoldDB; P10586; -.
DR   SMR; P10586; -.
DR   BioGRID; 111756; 245.
DR   IntAct; P10586; 48.
DR   MINT; P10586; -.
DR   STRING; 9606.ENSP00000353030; -.
DR   BindingDB; P10586; -.
DR   ChEMBL; CHEMBL3521; -.
DR   GuidetoPHARMACOLOGY; 1855; -.
DR   DEPOD; PTPRF; -.
DR   GlyConnect; 1708; 21 N-Linked glycans (4 sites).
DR   GlyCosmos; P10586; 7 sites, 21 glycans.
DR   GlyGen; P10586; 8 sites, 21 N-linked glycans (4 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; P10586; -.
DR   PhosphoSitePlus; P10586; -.
DR   SwissPalm; P10586; -.
DR   BioMuta; PTPRF; -.
DR   DMDM; 226709091; -.
DR   EPD; P10586; -.
DR   jPOST; P10586; -.
DR   MassIVE; P10586; -.
DR   MaxQB; P10586; -.
DR   PaxDb; P10586; -.
DR   PeptideAtlas; P10586; -.
DR   ProteomicsDB; 52612; -. [P10586-1]
DR   ProteomicsDB; 52613; -. [P10586-2]
DR   ABCD; P10586; 7 sequenced antibodies.
DR   Antibodypedia; 2499; 351 antibodies from 32 providers.
DR   DNASU; 5792; -.
DR   Ensembl; ENST00000359947.9; ENSP00000353030.4; ENSG00000142949.17. [P10586-1]
DR   Ensembl; ENST00000438120.5; ENSP00000398822.1; ENSG00000142949.17. [P10586-2]
DR   GeneID; 5792; -.
DR   KEGG; hsa:5792; -.
DR   MANE-Select; ENST00000359947.9; ENSP00000353030.4; NM_002840.5; NP_002831.2.
DR   UCSC; uc001cjr.4; human. [P10586-1]
DR   AGR; HGNC:9670; -.
DR   CTD; 5792; -.
DR   DisGeNET; 5792; -.
DR   GeneCards; PTPRF; -.
DR   HGNC; HGNC:9670; PTPRF.
DR   HPA; ENSG00000142949; Low tissue specificity.
DR   MalaCards; PTPRF; -.
DR   MIM; 179590; gene.
DR   MIM; 616001; phenotype.
DR   neXtProt; NX_P10586; -.
DR   OpenTargets; ENSG00000142949; -.
DR   Orphanet; 180188; Isolated congenital breast hypoplasia/aplasia.
DR   PharmGKB; PA34015; -.
DR   VEuPathDB; HostDB:ENSG00000142949; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   GeneTree; ENSGT00940000155060; -.
DR   HOGENOM; CLU_001645_4_0_1; -.
DR   InParanoid; P10586; -.
DR   OMA; VIRSANY; -.
DR   OrthoDB; 2875525at2759; -.
DR   PhylomeDB; P10586; -.
DR   TreeFam; TF312900; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   PathwayCommons; P10586; -.
DR   Reactome; R-HSA-388844; Receptor-type tyrosine-protein phosphatases.
DR   Reactome; R-HSA-77387; Insulin receptor recycling.
DR   Reactome; R-HSA-8849932; Synaptic adhesion-like molecules.
DR   SignaLink; P10586; -.
DR   SIGNOR; P10586; -.
DR   BioGRID-ORCS; 5792; 10 hits in 1172 CRISPR screens.
DR   ChiTaRS; PTPRF; human.
DR   EvolutionaryTrace; P10586; -.
DR   GeneWiki; PTPRF; -.
DR   GenomeRNAi; 5792; -.
DR   Pharos; P10586; Tchem.
DR   PRO; PR:P10586; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P10586; protein.
DR   Bgee; ENSG00000142949; Expressed in gingival epithelium and 198 other tissues.
DR   ExpressionAtlas; P10586; baseline and differential.
DR   Genevisible; P10586; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:SynGO-UCL.
DR   GO; GO:0035373; F:chondroitin sulfate proteoglycan binding; IEA:Ensembl.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:1900121; P:negative regulation of receptor binding; IMP:UniProtKB.
DR   GO; GO:0031102; P:neuron projection regeneration; IEA:Ensembl.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IMP:UniProtKB.
DR   GO; GO:0048679; P:regulation of axon regeneration; IEA:Ensembl.
DR   GO; GO:0099560; P:synaptic membrane adhesion; IDA:SynGO.
DR   GO; GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; TAS:ProtInc.
DR   CDD; cd00063; FN3; 8.
DR   CDD; cd05738; IgI_2_RPTP_IIa_LAR_like; 1.
DR   CDD; cd05739; IgI_3_RPTP_IIa_LAR_like; 1.
DR   CDD; cd14629; R-PTP-F-2; 1.
DR   CDD; cd14626; R-PTPc-F-1; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 11.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTP_cat.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   PANTHER; PTHR46957; CYTOKINE RECEPTOR; 1.
DR   PANTHER; PTHR46957:SF1; PHOSPHATIDYLINOSITOL PHOSPHATASE PTPRQ; 1.
DR   Pfam; PF00041; fn3; 7.
DR   Pfam; PF07679; I-set; 3.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00014; FNTYPEIII.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 8.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 2.
DR   SUPFAM; SSF49265; Fibronectin type III; 5.
DR   SUPFAM; SSF48726; Immunoglobulin; 3.
DR   PROSITE; PS50853; FN3; 8.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Disulfide bond;
KW   Glycoprotein; Heparin-binding; Hydrolase; Immunoglobulin domain; Membrane;
KW   Phosphoprotein; Protein phosphatase; Receptor; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..29
FT                   /evidence="ECO:0000255"
FT   CHAIN           30..1907
FT                   /note="Receptor-type tyrosine-protein phosphatase F"
FT                   /id="PRO_0000025432"
FT   TOPO_DOM        30..1263
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1264..1284
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1285..1907
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          33..123
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          135..224
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          232..314
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          321..411
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          416..510
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          514..604
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          609..706
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          711..819
FT                   /note="Fibronectin type-III 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          820..914
FT                   /note="Fibronectin type-III 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          918..1010
FT                   /note="Fibronectin type-III 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1014..1098
FT                   /note="Fibronectin type-III 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1352..1607
FT                   /note="Tyrosine-protein phosphatase 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   DOMAIN          1639..1898
FT                   /note="Tyrosine-protein phosphatase 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          398..417
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          693..712
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1548
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000305"
FT   ACT_SITE        1839
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250"
FT   BINDING         68..77
FT                   /ligand="heparin"
FT                   /ligand_id="ChEBI:CHEBI:28304"
FT                   /evidence="ECO:0000250"
FT   BINDING         1516
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         1548..1554
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         1592
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1305
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   CARBOHYD        117
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        250
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        295
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        721
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        966
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19349973"
FT   DISULFID        54..107
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        156..207
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        253..298
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         772..780
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:15491607"
FT                   /id="VSP_036617"
FT   VARIANT         412
FT                   /note="A -> V (in dbSNP:rs1065775)"
FT                   /id="VAR_054766"
FT   VARIANT         450
FT                   /note="Y -> C (in dbSNP:rs3748796)"
FT                   /id="VAR_020299"
FT   VARIANT         562
FT                   /note="D -> N (in dbSNP:rs3748800)"
FT                   /id="VAR_020300"
FT   MUTAGEN         1548
FT                   /note="C->S: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10338209"
FT   CONFLICT        646
FT                   /note="Y -> H (in Ref. 1; CAA68754)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1421
FT                   /note="I -> T (in Ref. 5; AAH48768)"
FT                   /evidence="ECO:0000305"
FT   STRAND          31..37
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          42..45
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          50..60
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          63..68
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   TURN            75..77
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          78..83
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   HELIX           84..86
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          88..93
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   HELIX           98..101
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          103..111
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          114..125
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   HELIX           127..129
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          136..139
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          144..147
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          152..154
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          157..159
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          165..170
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   HELIX           177..179
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          183..186
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          192..194
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   HELIX           199..201
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          203..211
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          214..217
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          221..226
FT                   /evidence="ECO:0007829|PDB:2YD8"
FT   STRAND          323..330
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          335..340
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          349..356
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          364..369
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          371..376
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          384..392
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          397..400
FT                   /evidence="ECO:0007829|PDB:6TPW"
FT   STRAND          404..407
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          418..428
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          430..435
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          444..453
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   HELIX           459..461
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          462..467
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          469..475
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          483..494
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          503..506
FT                   /evidence="ECO:0007829|PDB:6TPV"
FT   STRAND          519..522
FT                   /evidence="ECO:0007829|PDB:6TPU"
FT   STRAND          524..526
FT                   /evidence="ECO:0007829|PDB:6TPU"
FT   STRAND          528..531
FT                   /evidence="ECO:0007829|PDB:6TPU"
FT   STRAND          540..549
FT                   /evidence="ECO:0007829|PDB:6TPU"
FT   HELIX           550..552
FT                   /evidence="ECO:0007829|PDB:6TPU"
FT   STRAND          556..561
FT                   /evidence="ECO:0007829|PDB:6TPU"
FT   STRAND          565..569
FT                   /evidence="ECO:0007829|PDB:6TPU"
FT   STRAND          577..586
FT                   /evidence="ECO:0007829|PDB:6TPU"
FT   STRAND          597..600
FT                   /evidence="ECO:0007829|PDB:6TPU"
FT   STRAND          611..619
FT                   /evidence="ECO:0007829|PDB:4N5U"
FT   STRAND          622..628
FT                   /evidence="ECO:0007829|PDB:4N5U"
FT   HELIX           632..634
FT                   /evidence="ECO:0007829|PDB:4N5U"
FT   STRAND          639..652
FT                   /evidence="ECO:0007829|PDB:4N5U"
FT   STRAND          657..663
FT                   /evidence="ECO:0007829|PDB:4N5U"
FT   STRAND          667..671
FT                   /evidence="ECO:0007829|PDB:4N5U"
FT   STRAND          679..690
FT                   /evidence="ECO:0007829|PDB:4N5U"
FT   STRAND          692..695
FT                   /evidence="ECO:0007829|PDB:4N5U"
FT   STRAND          699..702
FT                   /evidence="ECO:0007829|PDB:4N5U"
FT   STRAND          825..830
FT                   /evidence="ECO:0007829|PDB:2DN7"
FT   STRAND          835..841
FT                   /evidence="ECO:0007829|PDB:2DN7"
FT   STRAND          852..859
FT                   /evidence="ECO:0007829|PDB:2DN7"
FT   STRAND          866..871
FT                   /evidence="ECO:0007829|PDB:2DN7"
FT   STRAND          876..880
FT                   /evidence="ECO:0007829|PDB:2DN7"
FT   STRAND          887..896
FT                   /evidence="ECO:0007829|PDB:2DN7"
FT   STRAND          899..909
FT                   /evidence="ECO:0007829|PDB:2DN7"
FT   STRAND          920..923
FT                   /evidence="ECO:0007829|PDB:2EDY"
FT   STRAND          925..927
FT                   /evidence="ECO:0007829|PDB:2EDY"
FT   STRAND          935..937
FT                   /evidence="ECO:0007829|PDB:2EDY"
FT   STRAND          950..957
FT                   /evidence="ECO:0007829|PDB:2EDY"
FT   STRAND          963..971
FT                   /evidence="ECO:0007829|PDB:2EDY"
FT   STRAND          984..987
FT                   /evidence="ECO:0007829|PDB:2EDY"
FT   HELIX           1334..1344
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   TURN            1347..1349
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1350..1358
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1368..1371
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   TURN            1373..1375
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1376..1378
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   TURN            1388..1390
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   TURN            1401..1404
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1407..1413
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1416..1423
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   TURN            1428..1430
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1431..1440
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1445..1448
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1452..1454
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1466..1472
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1475..1484
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1486..1497
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1503..1511
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1516..1518
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1524..1536
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1544..1553
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1554..1571
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1572..1574
FT                   /evidence="ECO:0007829|PDB:6KR4"
FT   HELIX           1576..1584
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1594..1610
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1617..1619
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1620..1627
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1638..1644
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   TURN            1645..1647
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   TURN            1657..1660
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1662..1667
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   TURN            1677..1679
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   TURN            1690..1693
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1696..1700
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1703..1705
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1709..1712
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1717..1719
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1720..1729
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1734..1737
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1741..1743
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1746..1749
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1755..1757
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1759..1761
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1764..1773
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1775..1786
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   TURN            1787..1789
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1792..1800
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1805..1807
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1813..1828
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1835..1844
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1845..1862
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   STRAND          1863..1865
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1867..1874
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   TURN            1875..1877
FT                   /evidence="ECO:0007829|PDB:1LAR"
FT   HELIX           1885..1900
FT                   /evidence="ECO:0007829|PDB:1LAR"
SQ   SEQUENCE   1907 AA;  212879 MW;  4A7C14A2090EA88F CRC64;
     MAPEPAPGRT MVPLVPALVM LGLVAGAHGD SKPVFIKVPE DQTGLSGGVA SFVCQATGEP
     KPRITWMKKG KKVSSQRFEV IEFDDGAGSV LRIQPLRVQR DEAIYECTAT NSLGEINTSA
     KLSVLEEEQL PPGFPSIDMG PQLKVVEKAR TATMLCAAGG NPDPEISWFK DFLPVDPATS
     NGRIKQLRSG ALQIESSEES DQGKYECVAT NSAGTRYSAP ANLYVRVRRV APRFSIPPSS
     QEVMPGGSVN LTCVAVGAPM PYVKWMMGAE ELTKEDEMPV GRNVLELSNV VRSANYTCVA
     ISSLGMIEAT AQVTVKALPK PPIDLVVTET TATSVTLTWD SGNSEPVTYY GIQYRAAGTE
     GPFQEVDGVA TTRYSIGGLS PFSEYAFRVL AVNSIGRGPP SEAVRARTGE QAPSSPPRRV
     QARMLSASTM LVQWEPPEEP NGLVRGYRVY YTPDSRRPPN AWHKHNTDAG LLTTVGSLLP
     GITYSLRVLA FTAVGDGPPS PTIQVKTQQG VPAQPADFQA EVESDTRIQL SWLLPPQERI
     IMYELVYWAA EDEDQQHKVT FDPTSSYTLE DLKPDTLYRF QLAARSDMGV GVFTPTIEAR
     TAQSTPSAPP QKVMCVSMGS TTVRVSWVPP PADSRNGVIT QYSVAYEAVD GEDRGRHVVD
     GISREHSSWD LVGLEKWTEY RVWVRAHTDV GPGPESSPVL VRTDEDVPSG PPRKVEVEPL
     NSTAVHVYWK LPVPSKQHGQ IRGYQVTYVR LENGEPRGLP IIQDVMLAEA QWRPEESEDY
     ETTISGLTPE TTYSVTVAAY TTKGDGARSK PKIVTTTGAV PGRPTMMIST TAMNTALLQW
     HPPKELPGEL LGYRLQYCRA DEARPNTIDF GKDDQHFTVT GLHKGTTYIF RLAAKNRAGL
     GEEFEKEIRT PEDLPSGFPQ NLHVTGLTTS TTELAWDPPV LAERNGRIIS YTVVFRDINS
     QQELQNITTD TRFTLTGLKP DTTYDIKVRA WTSKGSGPLS PSIQSRTMPV EQVFAKNFRV
     AAAMKTSVLL SWEVPDSYKS AVPFKILYNG QSVEVDGHSM RKLIADLQPN TEYSFVLMNR
     GSSAGGLQHL VSIRTAPDLL PHKPLPASAY IEDGRFDLSM PHVQDPSLVR WFYIVVVPID
     RVGGSMLTPR WSTPEELELD ELLEAIEQGG EEQRRRRRQA ERLKPYVAAQ LDVLPETFTL
     GDKKNYRGFY NRPLSPDLSY QCFVLASLKE PMDQKRYASS PYSDEIVVQV TPAQQQEEPE
     MLWVTGPVLA VILIILIVIA ILLFKRKRTH SPSSKDEQSI GLKDSLLAHS SDPVEMRRLN
     YQTPGMRDHP PIPITDLADN IERLKANDGL KFSQEYESID PGQQFTWENS NLEVNKPKNR
     YANVIAYDHS RVILTSIDGV PGSDYINANY IDGYRKQNAY IATQGPLPET MGDFWRMVWE
     QRTATVVMMT RLEEKSRVKC DQYWPARGTE TCGLIQVTLL DTVELATYTV RTFALHKSGS
     SEKRELRQFQ FMAWPDHGVP EYPTPILAFL RRVKACNPLD AGPMVVHCSA GVGRTGCFIV
     IDAMLERMKH EKTVDIYGHV TCMRSQRNYM VQTEDQYVFI HEALLEAATC GHTEVPARNL
     YAHIQKLGQV PPGESVTAME LEFKLLASSK AHTSRFISAN LPCNKFKNRL VNIMPYELTR
     VCLQPIRGVE GSDYINASFL DGYRQQKAYI ATQGPLAEST EDFWRMLWEH NSTIIVMLTK
     LREMGREKCH QYWPAERSAR YQYFVVDPMA EYNMPQYILR EFKVTDARDG QSRTIRQFQF
     TDWPEQGVPK TGEGFIDFIG QVHKTKEQFG QDGPITVHCS AGVGRTGVFI TLSIVLERMR
     YEGVVDMFQT VKTLRTQRPA MVQTEDQYQL CYRAALEYLG SFDHYAT
//
